(Q35217843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1 reference

title

Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

porphyria cutanea tarda

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Luisa García-Buey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

José María Pajares

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Ricardo Moreno-Otero

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

1 reference

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

620-627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

1 reference

7 January 2021

Familial and sporadic porphyria cutanea: two different diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C: a review and update

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

High prevalence of hepatitis C virus infection in patients with porphyria cutanea tarda in Poland

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus infection detected by viral RNA analysis in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Extrahepatic manifestations of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda and hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C in patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda and antibodies to hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda in south-east New South Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

HCV infection in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus infection and porphyria cutanea tarda in Australasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Ascorbic acid deficiency in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus and GBV-C/hepatitis G virus in Argentine patients with porphyria cutanea tarda.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda remission

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900346-5

7 January 2021

10.1016/S0168-8278(03)00346-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12971974%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference